The Global Drug-Eluting Balloon Catheters Market Report by Global Insight Services is the single and trusted source of information for the Drug-Eluting Balloon Catheters Market. This report provides an analysis of the market impact of the latest market disruptions such as the Russian-Ukraine War and Covid-19. The report provides a qualitative analysis of the market using various frameworks such as Porters’ and PESTLE analysis. The report includes in-depth segmentation and market size data by category, product type, application, and region. The report also includes a comprehensive analysis of recent events such as key issues, trends and drivers, restraints and challenges, competitive landscape, and M&A activity in the market.
The global vacuum bearing market was valued at US$ 400 million in 2021 and it is anticipated to grow up to US$ 1.1 billion by 2031, at a CAGR of 10.7% during the forecast period.
Get Free Sample Copy of This Report –https://www.globalinsightservices.com/request-sample/GIS24323/
A drug-eluting balloon is a non-stent technology in which the vessel wall processes the effective homogeneous delivery of anti-proliferative drugs via an inflated balloon. Healthcare infrastructure has undergone significant changes in the last decade as technology has proliferated and healthcare research has expanded significantly. Rising obesity, an ageing population, and an increase in the prevalence of coronary artery disease are some of the factors driving demand for drug-eluting balloon catheters. When stents are used in conjunction with a balloon catheter, they are referred to as balloon expandable stents, as opposed to self-expandable stents, which are typically made of nitinol alloy.
Market Drivers and Trends
The increasing prevalence of coronary artery disease among people all over the world is the primary driver of the industry’s growth. For example, according to the World Health Organization, approximately 3.8 million men and 4.4 million women will die from coronary heart disease. Furthermore, the number of deaths between the ages of 15 and 59 is approximately 1332 million, and the number of deaths over the age of 60 is approximately 5825 million. Furthermore, according to the Centers for Disease Control and Prevention, coronary heart disease will be the most common type of heart disease in upcoming years, killing 382,820 people globally.
Furthermore, the industry’s growth will be driven by increasing prevalence of diabetes. According to the World Health Organization’s October 2018 report, diabetes is responsible for approximately 1.6 million deaths worldwide. According to the Centers for Disease Control and Prevention, diabetes has affected 537 million adults (20-79 years) worldwide in 2021, accounting for one in every ten people. China has the most diabetics in the world, with approximately 141 million people suffering from the disease. Diabetes is expected to affect approximately 174 million people in China by 2045. These factors are expected to drive the growth of the global Drug-Eluting Balloon Catheters Market.
Request For Customization –https://www.globalinsightservices.com/request-customization/GIS24323/
Global Drug-Eluting Balloon Catheters Market Segmental Overview
The report analyses the global Drug-Eluting Balloon Catheters Market based on product, end-user, and region.
Global Drug-Eluting Balloon Catheters Market by Product
Based on product, it is bifurcated into coronary artery disease, and peripheral vascular disease. The coronary artery disease segment is expected to be the largest segment in the Drug-Eluting Balloon Catheters Market in 2021. The coronary artery disease DCB catheters segment is USD 510 million, owing to the rising prevalence of cardiac disorders worldwide. The product’s use in the treatment of restenosis can also be attributed to the product’s growth. Coronary artery disease DCB catheters are also commonly used for revascularization, assisting in the restoration of blood flow to blocked veins and arteries, further enhancing segmental growth.
Global Drug-Eluting Balloon Catheters Market by End-User
Based on end-user, the Drug-Eluting Balloon Catheters Market is segmented into hospitals & clinics, ambulatory surgical centers, and catheterization laboratories. The ambulatory surgical centers segment dominated the market. The market for drug-eluting balloon catheters in ambulatory surgical centers is USD 400 million. This can be attributed to a shift in patient preference toward ambulatory surgical centers due to their affordability and high-quality treatment options. The incorporation of advanced equipment and technology at ASCs also contributes to the segment scenario. Several other critical factors, such as ASCs’ ability to provide low-risk surgeries and more convenient treatment settings, are also boosting the segment’s revenue.
Geographical Analysis of Global Drug-Eluting Balloon Catheters Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North America is dominating in the Drug-Eluting Balloon Catheters Market. North America drug-eluting balloon catheters market is poised to surpass USD 440 million, owing to rising occurrence of chronic disorders in the region. As per the National Institute of Diabetes and Digestive and Kidney Disease 2021 report, nearly 37 million people in America have chronic kidney disease, which accounts for 1 in 7 adults requiring catheterization for treatment. This is due to rising awareness, favorable government initiatives, and the region’s well-developed healthcare infrastructure.
Major Players in the Global Drug-Eluting Balloon Catheters Market
The key players studied in the global Drug-Eluting Balloon Catheters Market are B. Braun Melsungen AG, Medtronic, BD Interventional, Biotronik AG, Eurocor GmbH, MedAlliance, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, iVascular S.L.U, and Cook Medical among others.
For In-Depth Competitive Analysis, Purchase this Report –https://www.globalinsightservices.com/checkout/single_user/GIS24323/
Global Insight Services can help you:
- A 10-year forecast to help you make strategic decisions
- Deep segmentation that can be customized according to your requirements
- Free consultation with the chief analyst of the report
- Excel data pack included with every report purchase
- Robust and transparent research methodology
About the Global Insights service:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, USA. We are committed to providing the highest quality data, analytics and tools to meet all of our clients’ market research needs. With GIS, you can be assured of the quality of your results, robust and transparent research methodology, and excellent service.
Contact us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
Email: [email protected]
Website: https://www.globalinsightservices.com/
Phone: +1–833–761–1700